• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Enhanced macrophage polarization induced by COX-2 inhibitor-loaded Pd octahedral nanozymes for treatment of atherosclerosis

    2023-03-14 06:52:18MinXuChuchuRenYueZhouZynekHegerXioyngLingVojtechAdmNnLi
    Chinese Chemical Letters 2023年1期

    Min Xu,Chuchu Ren,Yue Zhou,Zynek Heger,Xioyng Ling,Vojtech Adm,*,Nn Li,*

    a School of Pharmaceutical Science and Technology,Tianjin University,Tainjin 300072,China

    b Department of Chemistry and Biochemistry,Mendel University in Brno,Brno CZ-613 00,Czech Republic

    Keywords:Atherosclerosis COX-2 inhibitor Pd octahedral nanozyme Macrophage polarization Anti-inflammation Antioxidation

    ABSTRACT Inhibition of foam cell formation is considered a promising treatment method for atherosclerosis,the leading cause of cardiovascular diseases worldwide.However,currently available therapeutic strategies have shown unsatisfactory clinical outcomes.Thus,herein,we design aloperine (ALO)-loaded and hyaluronic acid (HA)-modified palladium (Pd) octahedral nanozymes (Pd@HA/ALO) that can synergistically scavenge reactive oxygen species (ROS) and downregulate cyclooxygenase-2 (COX-2) expression to induce macrophage polarization,thus inhibiting foam cell formation to attenuate atherosclerosis.Due to the targeted effect of HA on stabilin-2 and CD44,which are overexpressed in atherosclerotic plaques,Pd@HA/ALO can actively accumulate in atherosclerotic plaques.Subsequently,the antioxidative effects of Pd octahedral nanozymes are mediated by their intrinsic superoxide dismutase- and catalase-like activities capable of effective scavenging of ROS.In addition,anti-inflammatory effects are mediated by controlled,on-demand near-infrared-triggered ALO release leading to inhibition of COX-2 expression.Importantly,the combined therapy can promote the polarization of macrophages to the M2 subtype by upregulating Arg-1 and CD206 expression and downregulating expression of TNF-α,IL-1β and IL-6,thereby inhibiting atherosclerosis-related foam cell formation.In conclusion,the presented in vitro and in vivo data demonstrate that Pd@HA/ALO enhanced macrophage polarization to reduce plaque formation,identifying an attractive treatment strategy for cardiovascular disease.

    Atherosclerosis,which is characterized by chronic inflammation of the arterial wall,is a major contributor to cardiovascular diseases and remains the leading cause of morbidity and mortality in industrialized countries [1,2].Lipid-regulating drugs are the primary treatment for atherosclerosis,but long-term disease remission is not achieved due to the adverse side effects [3–5].Other small molecule drugs,such as probucol,aspirin and indomethacin,have been widely used for the management of atherosclerosis [6–9].Unfortunately,these therapies are limited to mildly delaying the progression of atherosclerosis due to the nonspecific distribution throughout the body.Currently,studies have shown that macrophages play a crucial role in the development of atherosclerosis [10].In particular,different phenotypes of macrophages,including the proinflammatory classic (M1) and anti-inflammatory(M2) phenotypes,were found to affect the stability of atherosclerotic plaques [11–14].M1 macrophages are predominant during the formation of atherosclerosis,inducing inflammation by secreting proinflammatory cytokines such as tumor necrosis factor-α(TNFα),interleukin-1β(IL-1β) and interleukin-6 (IL-6) [15,16].In contrast,M2 macrophages produce anti-inflammatory cytokines and are associated with resolution of atherosclerosis [17].Therefore,alteration of the macrophage phenotype may be a strategy for the atherosclerosis management.

    Fortunately,anti-inflammatory strategies may effectively alter the balance of macrophage subtypes for treatment of atherosclerosis [18,19].Recent studies have found that cyclooxygenase-2 (COX-2),a member of the COX family,plays an important role in the inflammatory response [20,21].Interestingly,aloperine (ALO),an alkaloid extracted fromSophora alopecuroidesL.,have shown antiinflammatory activity in bothin vivoandin vitrosettings [22].As reported previously,ALO reduces the expression of COX-2,thereby exhibiting an anti-inflammatory effect and promoting the phenotypic transition of M1 macrophages to the M2 subtype,which is of utmost interest for atherosclerosis therapy [23].However,it is worth to note that efficient delivery of ALO to atherosclerotic lesions is notoriously difficult.Thus,ALO could substantially benefit from nanoparticle-based targeted delivery strategies that have been shown to provide major advantages (e.g.,improved bioavailability,efficacy and safety) not only in a therapy of cardiovascularrelated diseases [24–28].

    Scheme 1.Schematic illustration displaying (a) the preparation route of Pd@HA/ALO and (b) the therapeutic mechanism of Pd@HA/ALO in atherosclerosis treatment.

    Recent studies have indicated that nanoparticles with intrinsic antioxidative activity are promising next-generation therapies for the treatment of atherosclerosis [29–31].Specifically,through their antioxidative activity,these nanoparticles are able to regulate reactive oxygen species (ROS) for M1 to M2 phenotypic transition of macrophages,thus synergizing anti-inflammatory functions to effectively ameliorate atherosclerosis [32–35].Notably,noble metalbased nanozymes,particularly palladium (Pd) nanoparticles,have received substantial interest due to their good biocompatibility and excellent antioxidative properties,such as catalase (CAT) and superoxide dismutase (SOD) activities [36–39].More importantly,studies have shown that enzyme-like performance can be effectively adjusted by controlling the structure and crystal facets of Pd nanomaterials.In general,lower surface energy (111)-faceted Pd octahedrons have greater intrinsic antioxidative enzyme-like activities than higher surface energy (100)-faceted Pd nanocubes [40].

    In this study,we designed ALO-loaded and hyaluronic acid(HA)-modified Pd octahedral nanozymes (Pd@HA/ALO) with synergistic antioxidative and anti-inflammatory activities to alleviate atherosclerosis through M1 to M2 polarization of macrophages(Scheme 1).The as-prepared Pd@HA/ALO nanoparticles were used to treat atherosclerosis through following multifactorial mechanism: (1) Pd@HA/ALO actively targets atherosclerotic plaques through HA-modified surface exhibiting affinity to stabilin-2 and CD44,which both are highly expressed in atherosclerotic plaques.(2) Pd octahedral nanozymes exert efficient SOD- and CAT-like activities,by which they scavenge multiple ROS and promote antioxidative treatment.(3) Under near-infrared (NIR) irradiation,ALO is released from Pd@HA/ALO,thus inhibiting the expression of COX-2 to exert an anti-inflammatory effect.(4) Synergistic antioxidative and anti- inflammatory effects promote the polarization of macrophages from the M1 to M2 subtype,thereby preventing the formation of foam cells to attenuate atherosclerosis.An array of comprehensivein vitroandin vivoexperiments confirmed that the prepared nanozymes are able to prevent the progression of atherosclerosis and to stabilize atherosclerotic plaques.

    The preparation process of Pd@HA/ALO is shown in Scheme 1a.First,Pd nanocubes were prepared based on a solution method using PVP,AA and KBr as a stabilizing agent,reductive agent and capping agent,respectively.The obtained Pd nanocubes exhibited uniform cubic shapes with average sizes of 32 nm,as confirmed by TEM (Fig.1a).Next,the as-prepared Pd nanocubes were used as seeds to synthesize Pd octahedrons,demonstrated in the TEM micrograph (Fig.1b).Specifically,Pd atoms were deposited on the (100) facet through thermodynamic control,leading to the transformation of Pd nanocubes into octahedra dominated by the (111) facet [41].Finally,HA and ALO were subsequently adsorbed onto the surface to fabricate Pd@HA/ALO.This resulted in an increased particle size of ~50 nm (Fig.1c).It is worth to note that dynamic light scattering revealed larger diameter (68.67 nm) compared to TEM micrographs.This was likely caused by the HA coating increasing the hydrodynamic diameter of Pd@HA/ALO (Fig.S1 in Supporting information).Moreover,the zeta potential decreased from -18.9 ± 0.6 mV (Pd octahedron) to-27.1 ± 1.15 mV (Pd@HA/ALO),indicating the successful coating of HA (Fig.S2 in Supporting information).In addition,the highresolution TEM (HRTEM) micrographs (Figs.1d and e) revealed lattice fringes of 0.20 and 0.22 nm,attributed to the (100) plane of the Pd nanocubes and the (111) plane of the Pd octahedrons,respectively.In addition,elemental mapping confirmed that Pd,O and N were homogeneously dispersed throughout the Pd@HA/ALO(Fig.1f).Moreover,the powder XRD spectrum indicated preferential crystal growth along the (111) direction for the Pd octahedrons,which was consistent with the HRTEM results (Fig.1g).In the XPS (Fig.1h),the split energy between Pd 3d3/2(341.1 eV)and Pd 3d5/2(335.8 eV) was 5.3 eV,which indicated the existence of Pd0in the final products.The UV-vis spectra further showed that Pd@HA/ALO presented a broad absorption band from the UV to NIR window (Fig.1i),suggesting the potential of Pd@HA/ALO to serve as a photothermal material.Additionally,the stability of Pd@HA/ALO was investigated in water,phosphate-buffered saline(PBS,pH 7.4),Dulbecco’s modified Eagle’s medium (DMEM) and fetal bovine serum (FBS).After 5 days,the size and dispersion properties of Pd@HA/ALO were well maintained,demonstrating that Pd@HA/ALO was stable enough for relatively long storage (Fig.S3 and Table S2 in Supporting information).

    Fig.1.Preparation and characterization of the Pd@HA/ALO.(a) TEM image of Pd nanocubes.(b) TEM image of Pd octahedrons.(c) TEM image of Pd@HA/ALO.(d) HRTEM image of Pd nanocubes.(e) HRTEM image of Pd octahedrons.(f) Element mapping of Pd@HA/ALO.(g) XPS spectra of Pd@HA/ALO.(h) XRD patterns of Pd@HA/ALO.(i) UV-vis spectra of Pd cubes,Pd octahedrons and Pd@HA/ALO.

    We further assessed the release kinetics of ALO from Pd@HA/ALO-based drug delivery systemsin vitro.First,we detected the photothermal effect of Pd@HA/ALO upon 808 nm laser irradiation.As shown in Fig.2a,the Pd@HA/ALO solution exhibited a concentration-dependent temperature increase with a maximum temperature of 43.8°C under 808 nm laser irradiation,which was monitored by an IR camera (Fig.2b).Moreover,the photothermal conversion efficiency of Pd@HA/ALO was determined to be 27.83%(Fig.2c),indicating its excellent photothermal conversion properties.Then,we used NIR light to trigger the release of ALO from Pd@HA/ALO.Without the 808 nm laser,the amount of released ALO in pH 7.4 buffer was only 9.1% and 10.0% at 12 and 24 h,respectively (Fig.S4 in Supporting information).In contrast,after exposure to an 808 nm laser,the release percentage increased to 28.5% at 12 h and further reached 30.3% at 24 h,revealing that the NIR laser could efficiently control the release of ALO.This phenomenon is plausibly due to the rapid increase in local temperature generated from Pd@HA/ALO that increases the thermal vibration to weaken the interactions between ALO and Pd@HA to accelerate the release of ALO [42,43].

    To investigate the ROS scavenging abilities of Pd@HA/ALO,we detected two representatives of ROS,H2O2and superoxide anion (O2·-).As expected,Pd@HA/ALO possessed high H2O2scavenging activity in a concentration- and time-dependent manner(Fig.2d and Fig.S5 in Supporting information).Specifically,more than 70% of H2O2was eliminated within 5 min after exposure to 100 μg/mL Pd@HA/ALO.In addition,the CAT-like activity of Pd@HA/ALO (100 μg/mL) to scavenge H2O2was approximately equal to that of 9.47 ± 0.61 U/mL CAT (Fig.2e).Furthermore,typical EPR spectra were chosen to confirm the effect of Pd@HA/ALO on scavenging H2O2.The characteristic signal intensities of H2O2were reduced with increasing Pd@HA/ALO concentrations and incubation times,revealing the excellent H2O2scavenging capacity of Pd@HA/ALO (Figs.2f and g).

    Subsequently,we focused on the O2·-scavenging ability of Pd@HA/ALO.In this study,the O2·-concentration was reduced with increasing Pd@HA/ALO concentration and incubation time(Fig.2h and Fig.S6 in Supporting information).Specifically,approximately 60% of the O2·-was decomposed after treatment with 200 μg/mL Pd@HA/ALO.In addition,the SOD-like activity of Pd@HA/ALO was shown to be concentration-dependent (Fig.2i).The O2·-scavenging efficiency of Pd@HA/ALO (200 μg/mL) was determined to be approximately equal to that of 15.70 ± 1.55 U/mL SOD.Moreover,the EPR spectra further demonstrated that Pd@HA/ALO exhibited a high O2·-scavenging capacity (Figs.2j and k).Overall,these results confirmed that Pd@HA/ALO provided dual enzyme-like activity (SOD and CAT) to scavenge ROS,which is highly beneficial for antioxidative-based therapeutic interventions.

    Fig.2.Photothermal effect and multienzyme-like antioxidative activities of Pd@HA/ALO.(a) Temperature curves of different concentrations of Pd@HA/ALO in 5 min under 808 nm laser irradiation (1.0 W/cm2).(b) Photothermal images of water and Pd@HA/ALO under 808 nm laser irradiation (1.0 W/cm2).(c) Linear correlation of the cooling times versus negative natural logarithm of driving force temperature.(d) H2O2 scavenging ability after treated with different concentrations of Pd@HA/ALO for 5 min.(e) The CAT-like activity of Pd@HA/ALO.Data are mean ± SD (n=3).(f) Concentration-dependent EPR spectra of Pd@HA/ALO for H2O2 scavenging.(g) Time-dependent EPR spectra of Pd@HA/ALO for H2O2 scavenging.(h) O2·- scavenging ability after treated with different concentrations of Pd@HA/ALO for 30 min.(i) SOD-like activity of Pd@HA/ALO.Data are mean ± SD (n=3).(j) Concentration-dependent EPR spectra of Pd@HA/ALO for O2·- scavenging.(k) Time-dependent EPR spectra of Pd@HA/ALO for O2·- scavenging.

    Encouraged by the outstanding ROS scavenging ability of Pd@HA/ALO,we next studied its biocompatibilityin vitro.First,we assessed the hemocompatibility of Pd@HA/ALO after incubation with erythrocytes (Fig.3a).No significant hemolysis (approximately 10%) of Pd@HA/ALO was observed even when the concentration was 200 μg/mL,which is in line with a negative surface charge of Pd@HA/ALO.Subsequently,analyses of cytotoxicity in RAW264.7 cells showed that Pd@HA/ALO induced only negligible cytotoxicity even at the maximum concentration (200 μg/mL),suggesting excellent cytocompatibility (Fig.3b).Notably,Pd@HA/ALO induced slight cytotoxicity after exposure to the NIR laser due to induced hyperthermia (Fig.3c).

    Subsequently,we investigated the cellular uptake behavior of Pd@HA/ALO using confocal microscopy and TEM.For this purpose,RAW264.7 macrophages were incubated with fluorescein isothiocyanate (FITC)-labeled Pd@HA/ALO for 1,3,6,9 and 12 h.Spatial FITC fluorescence (green color) exhibited a gradually increasing trend and reached a maximum at 9 h,confirming the successful cellular internalization of Pd@HA/ALO (Fig.3d and Fig.S7 in Supporting information).According to the colocalization analysis,although the green fluorescence signals were largely co-localized with the red color of LysoTracker after 9 h of incubation (Pearson’s correlation coefficient 0.55 ± 0.02),separated green fluorescence was observed at 12 h (Pearson’s correlation coefficient 0.39± 0.05),indicating that the Pd@HA/ALO could effectively achieve endolysomal escape after internalization (Fig.S8 in Supporting information).Furthermore,after 12 h,penetration of the endolysosomal membrane by Pd@HA/ALO was observed leading to the release of Pd@HA/ALO into the cytoplasm (Fig.3e).Therefore,these results confirmed that Pd@HA/ALO could be endocytosed effectively by RAW264.7 macrophages,which is a crucial prerequisite for a successful treatment of atherosclerosis.

    Compared with other cells,during atherosclerosis,macrophages are more susceptible to oxidative stress.Therefore,the macrophage-mediated protection against ROS-induced oxidative damage and subsequent initiation of a cascade of pathological processes during the early stage of atherosclerosis significantly attenuate its progression.Thus,we further examined antioxidative activity of Pd@HA/ALO in RAW264.7 macrophages.As shown in the calcein-AM and propidium iodide (PI) co-staining assays,the addition of Pd@HA/ALO led to an efficient inhibition of induction of apoptosis triggered by H2O2treatment (Fig.3f).Subsequently,flow cytometric analysis was performed to further validate the cytoprotective ability of Pd@HA/ALO (Fig.3g).Compared with that of the model group,a higher viable proportion (84.1%) and a lower apoptotic proportion (5.2%) of RAW264.7 macrophages were achieved after Pd@HA/ALO+NIR treatment,which is consistent with the results of the calcein-AM/PI co-staining.

    Fig.3. In vitro cytotoxicity,cellular internalization and antioxidation of Pd@HA/ALO.(a) Hemolysis of red blood cells after incubation with different concentrations of Pd@HA/ALO for 2 h.Inset: hemolysis photograph after centrifugation.Data are mean ± SD (n=3).(b) Relative cell viability of RAW264.7 cells after treated with different concentrations of Pd@HA/ALO without NIR laser irradiation for 24 and 48 h.(c) Relative cell viability of RAW264.7 cells after treated with different concentrations of Pd@HA/ALO with NIR laser irradiation for 24 and 48 h.Data are mean ± SD (n=5).**P<0.01.(d) CLSM images of time-dependent cellular uptake of FITC-labeled Pd@HA/ALO.Scale bar: 10 μm.(e) Representative bio-TEM images of RAW264.7 cells after incubated with Pd@HA/ALO for 6 and 12 h.(f) CLSM images of calcein-AM and PI co-staining RAW264.7 cells after different treatments.Scale bar: 100 μm.(g) Flow cytometry analysis of RAW264.7 cells after different treatments.

    Further,we also studied the directin vitroROS scavenging activity of Pd@HA/ALO in RAW264.7 cells.As shown in Fig.4a,the intracellular total ROS (green fluorescent signal),H2O2(green fluorescent signal) and O2·-(red fluorescent signal) levels increased dramatically after LPS treatment.Comparatively,the intracellular fluorescent signals of total ROS,H2O2and O2·-decreased significantly when the cells were incubated with Pd@HA/ALO.Notably,after irradiation with an NIR laser,RAW264.7 cells in the Pd@HA/ALO group presented lower free radical fluorescence than those without irradiation (Figs.S9-S11 in Supporting information).Quantitative analysis of intracellular total ROS levelsviaflow cytometry further confirmed this observation (Fig.4b).Taken together,these results demonstrate that Pd@HA/ALO nanoparticles significantly reduce intracellular ROS levels and protect RAW264.7 macrophages against ROS-induced oxidative damage.

    Subsequently,we also investigated whether Pd@HA/ALO possessed an anti-inflammatory effect in macrophages.As shown in Fig.4c,LPS-stimulated RAW264.7 cells showed significantly increased mRNA expression of COX-2,which plays a crucial role in the inflammatory behavior of activated macrophages.In contrast,the expression level of COX-2 was decreased after Pd@HA/ALO+NIR treatment,suggesting that the released ALO prominently inhibited COX-2 expression.Consequently,our results verified that Pd@HA/ALO could attenuate oxidation and inflammation in macrophages by inhibiting intracellular ROS and COX-2 production,respectively.

    We next evaluated thein vitromacrophage polarization (M1 to M2 phenotypic transition) after incubation with Pd@HA/ALO.As shown in Fig.4c,qRT-PCR analysis indicated that mRNA expression of proinflammatory M1 markers,including TNF-α,IL-1βand IL-6,was significantly increased after treatment with LPS.However,compared with the Pd@HA/ALO group,the Pd@HA/ALO+NIR group showed substantially reduced expression levels of proinflammatory M1 markers,indicating the increased release of ALO by NIR-induced hyperthermia.Moreover,the expression of representative M2 markers,including Arg-1 and CD206,was upregulated in the Pd@HA/ALO treatment group compared with the other groups.This results verified that Pd@HA/ALO could successfully promote the M1 to M2 phenotypic transition of macrophages through synergistic antioxidant and anti-inflammatory effects.

    Subsequently,we explored the inhibitory effect of Pd@HA/ALO treatment on foam cell formation.For this purpose,RAW264.7 macrophages treated with 50 μg/mL oxLDL for 24 h presented many intracellular lipid droplets and significant foam cell formation,as illustrated by staining with Oil Red O (ORO) (Fig.4d).Compared with the model group,the Pd@HA/ALO group showed notably suppressed foam cell formation,especially after NIR irradiation.Quantification of intracellularly deposited ORO supported this microscopic observation (P<0.01) (Fig.4e).Taken together,these results demonstrated that Pd@HA/ALO could suppress the formation of foam cells by inducing phenotypic alteration of macrophages from M1 to M2.

    Fig.4.Effect of Pd@HA/ALO on antioxidation,anti-inflammation and foam cell formation.(a) CLSM images showing intracellular ROS of RAW264.7 cells after different treatments.Intracellular total ROS,H2O2 and O2·- were stained by DCFH-DA,H2O2 probe and DHE,respectively.Scale bar: 20 μm.(b) ROS levels of RAW264.7 cells after different treatments.(c) mRNA expression of M1 (TNF-α,IL-1β,and IL-6),M2 (Arg-1 and CD206) macrophage markers and COX-2 in RAW264.7 cells after different treatments,as evaluated by qRT-PCR analysis.Data are mean ± SD (n=3).*P<0.05.(d) Optical microscopy images showing oxLDL-induced foam cell formation in RAW264.7 cells after different treatments.Ⅰ: Control; Ⅱ: Model; Ⅲ: Pd@HA/ALO; Ⅳ: Pd@HA/ALO+NIR.Scale bar: 50 μm.(e) Quantified contents of ORO in foam cells derived from RAW264.7 cells after different treatments.Data are mean ± SD (n=3).**P<0.01,***P<0.001,ns: no significance.

    To study the anti-atherosclerotic effectsin vivo,we first investigated the pharmacokinetic profiles of Pd@HA/ALO in C57BL/6 mice.All animal care and experimental protocols were approved by The Animal Ethics Committee of the Chinese Academy of Medical Sciences Institute of Radiology.After i.v.injection,fluorescence imaging results suggested that the signal of ZnPc-labeled Pd@HA/ALO increased with time (Figs.5a and b).This trend was different from the standard exponential damping of i.v.injected drugs,which was mainly reflected the non-linear profile of fluorescence signal accumulation and fluorescent substance decay.Then,we investigated thein vivotargeting ability in atherosclerotic plaque-bearingApoE-/-mice.After i.v.injection for 4 h,fluorescence imaging showed that ZnPc-labeled Pd@HA/ALO accumulated in isolated entire aortas (Fig.5c).At 12 h post-injection,imaging showed significantly stronger fluorescent signals in the isolated aortas,indicating that Pd@HA/ALO could target atherosclerotic plaques (Figs.5c and d).Moreover,the accumulation of Pd@HA/ALO in major organs,including the heart,liver,spleen,lung,and kidneys,showed a timedependent profile (Figs.S12 and S13 in Supporting information).In addition,the ability of Pd@HA/ALO to target atherosclerotic aortas was further demonstrated by immunofluorescence analysis.In this study,fluorescence imaging showed the substantial distribution of ZnPc-labeled Pd@HA/ALO in the aortic root and aortic arch (Fig.5e,Figs.S14 and S15 in Supporting information).In particular,the red fluorescence (ZnPc) of Pd@HA/ALO displayed relatively high colocalization with the green fluorescence of CD68+macrophages and CD31+endothelial cells,revealing that the HA modification enhanced the atherosclerotic plaque-targeting capabilityin vivo.Thus,Pd@HA/ALO with targeted drug delivery allowed subsequent local drug release and efficient atherosclerosis management,resulting from decreased phagocytosis and sustained local drug release.

    In addition,the ability of Pd@HA/ALO to target atherosclerotic aortas was further demonstrated by immunofluorescence analysis.In this study,fluorescence imaging showed the substantial distribution of ZnPc-labeled Pd@HA/ALO in the aortic root and aortic arch (Fig.5e,Figs.S14 and S15).In particular,the red fluorescence (ZnPc) of Pd@HA/ALO displayed relatively high colocalization with the green fluorescence of CD68+macrophages and CD31+endothelial cells,revealing that the HA modification enhanced the atherosclerotic plaque-targeting capabilityin vivo.Thus,Pd@HA/ALO with targeted drug delivery allowed subsequent local drug release and efficient atherosclerosis management,resulting from decreased phagocytosis and sustained local drug release.

    After confirming the significant accumulation of Pd@HA/ALO within plaques,we assessed the therapeutic effect inApoE-/-mice.ApoE-/-mice were fed a high-fat diet for 10 weeks.At 1 week,the animals were randomized into 4 groups with different treatments: control (C57BL/6 mice),model (saline),Pd@HA/ALO (10 mg/kg) and Pd@HA/ALO (10 mg/kg)+NIR.Mice received twiceweekly i.v.injections for a total of 10 weeks.After treatment,the whole aortas were harvested and stained with ORO.Atherosclerotic lesions identified by ORO staining were present in the model group,and the lesion area of the plaque in the Pd@HA/ALO treatment group was significantly reduced compared with that of the model group (Fig.5f).Importantly,the highest decrease in the ORO-stained areas in aortas was observed for the mice in the NIR irradiation group.Consistent with this result,the ORO-stained cryosections from the aortic root also revealed the extent of plaque reduction in the vascular lumen (Fig.5g).Further quantification of the ORO-stained plaques showed that the ratio of the plaque area to that of the whole aorta was decreased from 21.29% to 14.56% after treatment with Pd@HA/ALO (Fig.5h).In addition,Pd@HA/ALO+NIR treatment achieved a significantly higher therapeutic efficacy,as shown by a plaque ratio of 9.24%,revealing that the NIR-triggered release of ALO strongly inhibits atherosclerotic development.Compared with that of the model group (40.00%),the plaque area ratio decreased to 32.93% and 24.90% after treatment with Pd@HA/ALO and Pd@HA/ALO+NIR,respectively (Fig.5i),confirming that Pd@HA/ALO could effectively attenuate the progression of atherosclerosis.

    Fig.5. In vivo targeting ability and therapeutic effects of Pd@HA/ALO.(a) Ex vivo images of whole blood collected at various time points after i.v.administration of ZnPclabeled Pd@HA/ALO.(b) Quantified data of fluorescence intensities.Data are mean ± SD (n=3).(c) Ex vivo fluorescence images and (d) quantitative data of fluorescence signals accumulated in the aorta at 4 and 12 h points after i.v.administration of ZnPc-labeled Pd@HA/ALO.Data are mean ± SD (n=3).(e) Immunofluorescence analysis of the colocalization of ZnPc-labeled Pd@HA/ALO with CD68+ macrophages in the aortic root.Scale bar: 100 μm.(f) Representative ORO-stained images of aortas in each group.(g) Representative ORO-stained images of aortic roots sections in each group.Scale bar: 100 μm.(h) Quantitative data of the atherosclerotic plaque area.(i) Quantitative data of the atherosclerotic plaque area in the aortic root sections.Data are mean ± SD (n=5).(j) Serum levels of LDL in ApoE-/- mice after different treatments.(k) Serum levels of total cholesterol in ApoE-/- mice after different treatments.Data are mean ± SD (n=3).*P<0.05,**P<0.01,***P<0.001,ns: no significance.

    Subsequently,the composition of atherosclerotic plaques in aortic root sections was detected by H&E staining and immunohistochemistry.Examination of the H&E-stained sections of aortic roots showed that plaques in the model group largely consisted of acellular and lipid-rich necrotic cores (Fig.S16a in Supporting information).After treatment with Pd@HA/ALO,the necrotic area was notably decreased.Specifically,the quantitative analysis indicated that the necrotic core area was decreased from 26.86% to 16.42% after treatment with Pd@HA/ALO+NIR (Fig.S16b in Supporting information).Further separate immunohistochemical analyses for CD68 (a macrophage marker) and MMP-9 indicated that the number of macrophages and the level of MMP-9 were dramatically reduced in the atherosclerotic plaque area after treatment with Pd@HA/ALO,particularly after NIR irradiation (Figs.S17a-c in Supporting information).These findings indicated that Pd@HA/ALO can effectively suppress the progression of atherosclerosis due to the blockade of macrophage infiltration and the stabilization of vulnerable plaques.Concordant with these findings,staining with Masson’s trichrome showed a higher content of collagen around plaques of the Pd@HA/ALO-treated groups,resulting in enhanced fibrous cap thickness (Figs.S17a and d in Supporting information).Moreover,the immunohistochemical analyses forα-SMA (an SMC marker) demonstrated a high accumulation of SMCs in plaques in the Pd@HA/ALO-treated groups,indicating that vascular SMC proliferation was beneficial at various stages of atherogenesis (Figs.S17a and e in Supporting information) [44].Accordingly,these results demonstrated that Pd@HA/ALO lowers the accumulation of macrophages in plaques,prevent the formation of vulnerable plaques and increase the number of SMCs,thereby effectively delaying the development of atherosclerosis.

    Finally,the possible adverse effects of Pd@HA/ALO were examined after 10 weeks treatment.The clinical biochemical analysis of ALT,AST,ALP,BUN and CREA revealed normal values,suggesting that the functions of the liver and kidney were barely impaired after treatment with different formulations (Fig.S18 in Supporting information).Additionally,the levels of HDL,LDL,TGs and TC were examined.Compared to the model groups,the Pd@HA/ALO and Pd@HA/ALO+NIR groups displayed lower levels of LDL and TC,whereas no distinguishable changes were found in the TGs and HDL levels (Fig.S18,Figs.5j and k).In addition,examination of H&E-stained sections of major organs (heart,liver,spleen,lung and kidney) showed no obvious tissue pathologies in the treated mice of all groups,which further confirmed the good biocompatibility of Pd@HA/ALO (Fig.S19 in Supporting information).Together,these findings indicated that Pd@HA/ALO possessed a good safety profile for long-term treatment.

    In summary,we successfully engineered an endogenous targeted Pd@HA/ALO nanozyme to enhance macrophage polarization(M1 to M2) for treatment of atherosclerosis.Pd@HA/ALO innately exhibited multiple antioxidant enzyme activities to degrade intracellular ROS,leading to an antioxidative effect.Moreover,the ALO released from Pd@HA/ALO inhibited the expression of COX-2,which further relieved the inflammatory state.Synergistic antioxidant and anti-inflammatory effects effectively promoted the polarization of macrophages from the M1 to M2 subtype,thus suppressing the formation of foam cells.Furthermore,Pd@HA/ALO displayed a desirable safety profile without notable side effects,even after long-term administration in mice.Overall,Pd@HA/ALO could be a blueprint for next-generation nanomedicine in cardiovascular disease treatment and prevention.

    Declaration of competing interest

    The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

    Acknowledgments

    This work was supported by the Young Elite Scientists Sponsorship Program by Tianjin (No.0701320001) and the Major Special Projects (No.0402080005).Furthermore,the financial support from the CEITEC 2020 Project (No.LQ1601) and the Ministry of Education,Youth and Sports of the Czech Republic under the National Sustainability Programme II and by ERDF (No.CZ.02.1.01/0.0/0.0/16_025/0007314) is highly acknowledged.

    Supplementary materials

    Supplementary material associated with this article can be found,in the online version,at doi:10.1016/j.cclet.2022.06.008.

    国产免费现黄频在线看| 久久精品国产亚洲网站| 人人妻人人添人人爽欧美一区卜| 国产成人免费无遮挡视频| 国产成人免费无遮挡视频| 一区二区三区乱码不卡18| 黄片播放在线免费| 大片电影免费在线观看免费| 久久精品国产自在天天线| 永久免费av网站大全| 尾随美女入室| 一级毛片aaaaaa免费看小| 亚洲精品国产av成人精品| 国产永久视频网站| 久久久久久久久久成人| 午夜免费男女啪啪视频观看| 久久亚洲国产成人精品v| 免费大片黄手机在线观看| 久久人妻熟女aⅴ| 只有这里有精品99| 又大又黄又爽视频免费| 国产亚洲午夜精品一区二区久久| 男男h啪啪无遮挡| 在现免费观看毛片| 久久久久久人妻| 亚洲av成人精品一区久久| a级片在线免费高清观看视频| 亚洲av二区三区四区| 亚洲国产精品一区二区三区在线| 91国产中文字幕| 亚洲国产av新网站| √禁漫天堂资源中文www| 亚洲色图综合在线观看| 精品一区二区三区视频在线| 亚洲av不卡在线观看| 国产免费又黄又爽又色| 五月开心婷婷网| 我的老师免费观看完整版| 肉色欧美久久久久久久蜜桃| 免费大片黄手机在线观看| 久久人妻熟女aⅴ| 日本av免费视频播放| 国产精品国产三级国产av玫瑰| 伦理电影免费视频| 午夜91福利影院| 51国产日韩欧美| 国产欧美日韩一区二区三区在线 | 国产精品人妻久久久久久| 国产精品一区二区三区四区免费观看| 亚洲激情五月婷婷啪啪| 成人手机av| 天堂俺去俺来也www色官网| 91aial.com中文字幕在线观看| 高清视频免费观看一区二区| 青春草国产在线视频| a 毛片基地| 亚洲高清免费不卡视频| 一级a做视频免费观看| 18在线观看网站| 99久久精品一区二区三区| 精品少妇内射三级| av网站免费在线观看视频| 在线播放无遮挡| 九九爱精品视频在线观看| 亚洲精品久久久久久婷婷小说| 三级国产精品欧美在线观看| 天天躁夜夜躁狠狠久久av| 边亲边吃奶的免费视频| 亚洲精品乱码久久久久久按摩| 超色免费av| 欧美日韩在线观看h| 久久精品久久久久久噜噜老黄| 国产精品人妻久久久影院| 日本爱情动作片www.在线观看| 国产无遮挡羞羞视频在线观看| 91精品一卡2卡3卡4卡| 久久免费观看电影| 久久综合国产亚洲精品| 久久久久久久大尺度免费视频| 亚洲,欧美,日韩| 国产极品天堂在线| 午夜免费鲁丝| 国产乱人偷精品视频| 人人妻人人澡人人爽人人夜夜| 国产欧美日韩综合在线一区二区| 91久久精品国产一区二区成人| 欧美 日韩 精品 国产| 一个人看视频在线观看www免费| 成人手机av| 综合色丁香网| 国产一级毛片在线| videosex国产| 中文精品一卡2卡3卡4更新| 丰满少妇做爰视频| 大又大粗又爽又黄少妇毛片口| 午夜福利网站1000一区二区三区| 一级毛片电影观看| 飞空精品影院首页| 高清午夜精品一区二区三区| 亚洲综合色网址| 久久久久网色| 国产精品人妻久久久久久| 超色免费av| 午夜免费鲁丝| 精品亚洲成a人片在线观看| 最近中文字幕2019免费版| 精品久久久久久电影网| 亚洲国产最新在线播放| 亚洲三级黄色毛片| 欧美日韩在线观看h| 国产高清有码在线观看视频| 亚洲国产精品国产精品| 中文天堂在线官网| 精品少妇久久久久久888优播| 18禁动态无遮挡网站| 成人亚洲精品一区在线观看| 日韩大片免费观看网站| 欧美日韩av久久| 热99久久久久精品小说推荐| 观看av在线不卡| 在线观看免费高清a一片| 欧美成人午夜免费资源| 中文天堂在线官网| av在线播放精品| 内地一区二区视频在线| 制服丝袜香蕉在线| 国产综合精华液| 国产精品久久久久久久久免| 大陆偷拍与自拍| 少妇人妻 视频| 日日爽夜夜爽网站| 久久久久久久亚洲中文字幕| 亚洲av中文av极速乱| 青青草视频在线视频观看| 国产一级毛片在线| 制服丝袜香蕉在线| 在线观看美女被高潮喷水网站| 国产精品久久久久久久久免| 大话2 男鬼变身卡| 免费av中文字幕在线| 麻豆精品久久久久久蜜桃| 人人妻人人爽人人添夜夜欢视频| 精品一区二区免费观看| 亚洲精品成人av观看孕妇| 成年女人在线观看亚洲视频| 欧美日韩在线观看h| 国产精品久久久久久av不卡| 成年女人在线观看亚洲视频| 免费播放大片免费观看视频在线观看| 五月天丁香电影| 考比视频在线观看| 久久99蜜桃精品久久| 亚洲欧美日韩卡通动漫| 亚洲丝袜综合中文字幕| 男人操女人黄网站| 日韩欧美精品免费久久| 国产成人午夜福利电影在线观看| 亚洲精品日韩av片在线观看| 国语对白做爰xxxⅹ性视频网站| 亚洲第一av免费看| av免费观看日本| 大片免费播放器 马上看| 欧美一级a爱片免费观看看| 久久久午夜欧美精品| 综合色丁香网| 久久久国产欧美日韩av| 久久热精品热| 亚洲,一卡二卡三卡| 久久精品国产鲁丝片午夜精品| 成人毛片60女人毛片免费| 18禁在线播放成人免费| 中文字幕人妻熟人妻熟丝袜美| 久久99一区二区三区| 国产视频首页在线观看| 久久久久久久大尺度免费视频| 99国产综合亚洲精品| 有码 亚洲区| 天堂俺去俺来也www色官网| 亚洲经典国产精华液单| √禁漫天堂资源中文www| 亚洲精品456在线播放app| 人体艺术视频欧美日本| 国产精品欧美亚洲77777| 亚洲精品中文字幕在线视频| 肉色欧美久久久久久久蜜桃| 国产视频首页在线观看| 午夜精品国产一区二区电影| 日本免费在线观看一区| 久久人人爽av亚洲精品天堂| 黄片无遮挡物在线观看| 能在线免费看毛片的网站| av专区在线播放| 五月伊人婷婷丁香| 丝袜脚勾引网站| 91精品三级在线观看| 精品久久久久久电影网| 久久99热6这里只有精品| 性高湖久久久久久久久免费观看| 亚洲av福利一区| 99热这里只有是精品在线观看| 国产精品.久久久| 又粗又硬又长又爽又黄的视频| 国产乱来视频区| 看十八女毛片水多多多| 日韩av免费高清视频| 成人二区视频| 九九在线视频观看精品| www.色视频.com| 九色成人免费人妻av| 久久人人爽av亚洲精品天堂| 午夜免费鲁丝| 91精品国产国语对白视频| a 毛片基地| 黄色欧美视频在线观看| 亚洲av二区三区四区| 久久精品人人爽人人爽视色| 黄片无遮挡物在线观看| 97超视频在线观看视频| av又黄又爽大尺度在线免费看| 九色成人免费人妻av| 亚洲高清免费不卡视频| 女的被弄到高潮叫床怎么办| 18+在线观看网站| 免费av不卡在线播放| 国产精品成人在线| 中文精品一卡2卡3卡4更新| 国产成人a∨麻豆精品| 丰满饥渴人妻一区二区三| 精品人妻在线不人妻| 日韩一本色道免费dvd| 免费久久久久久久精品成人欧美视频 | 日韩成人av中文字幕在线观看| 日韩亚洲欧美综合| 精品亚洲乱码少妇综合久久| 欧美激情国产日韩精品一区| 2022亚洲国产成人精品| 男女高潮啪啪啪动态图| 九色亚洲精品在线播放| 乱码一卡2卡4卡精品| av有码第一页| 国产国语露脸激情在线看| 99九九线精品视频在线观看视频| 美女国产高潮福利片在线看| 老女人水多毛片| 国产男女超爽视频在线观看| 欧美日韩精品成人综合77777| 国产精品熟女久久久久浪| 亚洲精华国产精华液的使用体验| 国产极品粉嫩免费观看在线 | 国产亚洲精品第一综合不卡 | 丰满迷人的少妇在线观看| 国产在线一区二区三区精| 18在线观看网站| 一本大道久久a久久精品| 高清视频免费观看一区二区| 黑人猛操日本美女一级片| av线在线观看网站| 26uuu在线亚洲综合色| 国产成人aa在线观看| 成人亚洲欧美一区二区av| 久久综合国产亚洲精品| 国产av一区二区精品久久| 亚洲伊人久久精品综合| 999精品在线视频| 亚洲欧美一区二区三区黑人 | 久久影院123| 涩涩av久久男人的天堂| 亚洲美女黄色视频免费看| 一本一本综合久久| 九草在线视频观看| 久久影院123| 天天影视国产精品| 免费观看a级毛片全部| 午夜91福利影院| 日韩欧美一区视频在线观看| av卡一久久| 精品午夜福利在线看| 人妻制服诱惑在线中文字幕| 免费大片黄手机在线观看| 亚洲精品一二三| 日日摸夜夜添夜夜添av毛片| 色5月婷婷丁香| 欧美最新免费一区二区三区| 国产成人精品在线电影| 亚洲国产欧美在线一区| 精品亚洲成a人片在线观看| 热99久久久久精品小说推荐| 黄片无遮挡物在线观看| 精品少妇久久久久久888优播| av电影中文网址| 黄色欧美视频在线观看| 成人黄色视频免费在线看| 一区二区三区乱码不卡18| 久久久精品免费免费高清| 国产精品无大码| av国产久精品久网站免费入址| 国产不卡av网站在线观看| 色婷婷av一区二区三区视频| 嘟嘟电影网在线观看| 久久女婷五月综合色啪小说| av国产精品久久久久影院| 一级毛片aaaaaa免费看小| 亚洲美女视频黄频| 韩国高清视频一区二区三区| 91午夜精品亚洲一区二区三区| 国产精品久久久久久av不卡| 亚洲无线观看免费| 色视频在线一区二区三区| 在线观看人妻少妇| 精品久久久久久久久亚洲| 欧美日韩av久久| 国产av精品麻豆| 免费大片18禁| 亚洲欧美成人精品一区二区| 亚洲国产欧美在线一区| 久久久久久久亚洲中文字幕| 日日撸夜夜添| 国产亚洲精品第一综合不卡 | 9色porny在线观看| 少妇的逼水好多| 一本色道久久久久久精品综合| 特大巨黑吊av在线直播| 欧美日韩视频精品一区| 亚洲欧美一区二区三区国产| 日本-黄色视频高清免费观看| 91精品国产国语对白视频| 欧美老熟妇乱子伦牲交| 亚洲精品国产色婷婷电影| 在线观看人妻少妇| 国产精品国产三级国产av玫瑰| 纯流量卡能插随身wifi吗| 亚洲精品视频女| 在现免费观看毛片| 精品熟女少妇av免费看| 性色avwww在线观看| 九草在线视频观看| 免费观看性生交大片5| 国产精品国产av在线观看| 一本色道久久久久久精品综合| 国产在线一区二区三区精| 一区在线观看完整版| 亚洲欧美日韩另类电影网站| 日韩一本色道免费dvd| 久久国内精品自在自线图片| 夫妻性生交免费视频一级片| 国产成人a∨麻豆精品| 热99久久久久精品小说推荐| 亚洲国产精品专区欧美| 久久久精品区二区三区| 亚洲精品久久午夜乱码| 在线观看一区二区三区激情| 爱豆传媒免费全集在线观看| 在线观看人妻少妇| 亚洲精品色激情综合| 国产在线一区二区三区精| 日韩中字成人| 国产欧美日韩一区二区三区在线 | 高清毛片免费看| 哪个播放器可以免费观看大片| 久久精品国产亚洲网站| 亚洲精品久久久久久婷婷小说| 美女国产高潮福利片在线看| 午夜福利网站1000一区二区三区| 国内精品宾馆在线| 永久网站在线| 老司机影院成人| 一级毛片黄色毛片免费观看视频| 国语对白做爰xxxⅹ性视频网站| 国产精品.久久久| 精品少妇久久久久久888优播| 一本一本久久a久久精品综合妖精 国产伦在线观看视频一区 | 精品国产一区二区三区久久久樱花| 亚洲精品av麻豆狂野| 欧美人与善性xxx| 国产精品女同一区二区软件| 伦精品一区二区三区| av天堂久久9| 午夜免费观看性视频| 国产男人的电影天堂91| 国产免费又黄又爽又色| 一本—道久久a久久精品蜜桃钙片| 亚洲精品一区蜜桃| 亚洲av.av天堂| 亚洲国产精品国产精品| 99热网站在线观看| av在线老鸭窝| 五月玫瑰六月丁香| 大又大粗又爽又黄少妇毛片口| 一本色道久久久久久精品综合| 国产色爽女视频免费观看| 国产成人免费观看mmmm| 乱码一卡2卡4卡精品| 久久久久久伊人网av| 日日啪夜夜爽| 18禁裸乳无遮挡动漫免费视频| 极品少妇高潮喷水抽搐| 极品人妻少妇av视频| 黑人巨大精品欧美一区二区蜜桃 | 久久午夜福利片| 色94色欧美一区二区| 美女福利国产在线| 人体艺术视频欧美日本| 日韩免费高清中文字幕av| 黑丝袜美女国产一区| 亚洲婷婷狠狠爱综合网| 精品国产露脸久久av麻豆| 免费观看的影片在线观看| 你懂的网址亚洲精品在线观看| 2021少妇久久久久久久久久久| 肉色欧美久久久久久久蜜桃| 国产精品嫩草影院av在线观看| 成年美女黄网站色视频大全免费 | 久久99蜜桃精品久久| 99热全是精品| 69精品国产乱码久久久| 亚洲人成网站在线播| 亚洲欧洲国产日韩| 新久久久久国产一级毛片| 日本wwww免费看| 精品亚洲成国产av| 久久久久精品久久久久真实原创| 久久精品国产a三级三级三级| 精品久久久久久电影网| 久久久a久久爽久久v久久| 亚洲精品乱久久久久久| 成年女人在线观看亚洲视频| 91久久精品国产一区二区三区| 18+在线观看网站| 国产成人av激情在线播放 | 国产精品三级大全| a级片在线免费高清观看视频| 丰满迷人的少妇在线观看| 伦精品一区二区三区| 中文字幕av电影在线播放| 日韩熟女老妇一区二区性免费视频| 亚洲成人手机| 狠狠婷婷综合久久久久久88av| 国产亚洲精品久久久com| 亚洲国产精品一区二区三区在线| av不卡在线播放| 成年美女黄网站色视频大全免费 | 欧美人与性动交α欧美精品济南到 | 在线精品无人区一区二区三| 久久久久人妻精品一区果冻| 欧美日本中文国产一区发布| 亚洲人成网站在线播| 国产老妇伦熟女老妇高清| 久久精品国产亚洲av涩爱| 最新中文字幕久久久久| 午夜91福利影院| av专区在线播放| 国产有黄有色有爽视频| 女人精品久久久久毛片| 久久韩国三级中文字幕| av线在线观看网站| 欧美精品一区二区大全| 18在线观看网站| 男女国产视频网站| 在线亚洲精品国产二区图片欧美 | 午夜久久久在线观看| 女的被弄到高潮叫床怎么办| 午夜福利在线观看免费完整高清在| 久久午夜综合久久蜜桃| 新久久久久国产一级毛片| 制服诱惑二区| 简卡轻食公司| 岛国毛片在线播放| 日韩中字成人| 99久久综合免费| 久久精品人人爽人人爽视色| 国语对白做爰xxxⅹ性视频网站| 成人毛片60女人毛片免费| 97精品久久久久久久久久精品| 国产黄频视频在线观看| 免费黄网站久久成人精品| 桃花免费在线播放| av视频免费观看在线观看| 欧美日韩视频高清一区二区三区二| www.av在线官网国产| 欧美日韩国产mv在线观看视频| 亚洲欧美精品自产自拍| 少妇熟女欧美另类| 人人妻人人澡人人看| av在线老鸭窝| 亚洲国产精品一区三区| 国产男女超爽视频在线观看| 美女国产高潮福利片在线看| 成人黄色视频免费在线看| 中文字幕人妻熟人妻熟丝袜美| 国产男人的电影天堂91| 欧美人与善性xxx| 午夜91福利影院| 母亲3免费完整高清在线观看 | 色视频在线一区二区三区| 国产男女超爽视频在线观看| 最近2019中文字幕mv第一页| 成人黄色视频免费在线看| 国产亚洲精品第一综合不卡 | 久久精品国产亚洲网站| 亚洲国产av新网站| 日韩精品免费视频一区二区三区 | 午夜福利影视在线免费观看| 国产黄色免费在线视频| av线在线观看网站| 黑人猛操日本美女一级片| 精品少妇黑人巨大在线播放| 最后的刺客免费高清国语| 欧美精品人与动牲交sv欧美| 中文字幕制服av| 亚洲精品乱久久久久久| 高清视频免费观看一区二区| 日韩欧美精品免费久久| 亚洲精品亚洲一区二区| 久久久久久久久久久丰满| 黑人猛操日本美女一级片| 国产精品.久久久| 亚洲国产色片| 五月伊人婷婷丁香| 一级爰片在线观看| 黄片播放在线免费| 色网站视频免费| 秋霞在线观看毛片| 精品国产一区二区久久| h视频一区二区三区| av国产精品久久久久影院| 亚洲av日韩在线播放| 日本黄色片子视频| 色吧在线观看| 欧美老熟妇乱子伦牲交| 亚洲综合精品二区| 欧美亚洲 丝袜 人妻 在线| 狠狠精品人妻久久久久久综合| 黑人高潮一二区| 尾随美女入室| 大香蕉97超碰在线| 91aial.com中文字幕在线观看| 久久精品国产亚洲av天美| 一级a做视频免费观看| 性高湖久久久久久久久免费观看| 精品一区二区三区视频在线| 亚洲天堂av无毛| 亚洲欧美色中文字幕在线| 精品少妇久久久久久888优播| 国产免费福利视频在线观看| 欧美 日韩 精品 国产| 在线观看三级黄色| 免费看光身美女| 夜夜骑夜夜射夜夜干| 亚洲精品,欧美精品| av在线app专区| 搡老乐熟女国产| 大陆偷拍与自拍| 少妇熟女欧美另类| 亚洲欧洲国产日韩| 80岁老熟妇乱子伦牲交| 久久午夜福利片| 只有这里有精品99| 国产成人精品一,二区| 最近中文字幕高清免费大全6| 亚洲欧美一区二区三区黑人 | 秋霞在线观看毛片| 国产精品国产三级国产av玫瑰| 欧美激情国产日韩精品一区| av不卡在线播放| 精品久久久久久久久亚洲| 久久这里有精品视频免费| 91久久精品国产一区二区成人| 91久久精品电影网| 熟妇人妻不卡中文字幕| 国产精品一区二区在线不卡| 欧美三级亚洲精品| 最近2019中文字幕mv第一页| 亚洲av成人精品一二三区| 日韩在线高清观看一区二区三区| 日韩视频在线欧美| 视频中文字幕在线观看| 国产免费福利视频在线观看| 狠狠精品人妻久久久久久综合| 男女高潮啪啪啪动态图| 在线天堂最新版资源| 久热久热在线精品观看| 高清av免费在线| 成人亚洲精品一区在线观看| 少妇人妻精品综合一区二区| 国产伦精品一区二区三区视频9| 少妇的逼水好多| 高清欧美精品videossex| 少妇被粗大猛烈的视频| 日韩欧美一区视频在线观看| 嫩草影院入口| 国产午夜精品久久久久久一区二区三区| 欧美精品高潮呻吟av久久| 免费观看无遮挡的男女| 国产极品天堂在线| tube8黄色片| 黑人高潮一二区| 女性生殖器流出的白浆| 建设人人有责人人尽责人人享有的| 桃花免费在线播放| 亚洲国产日韩一区二区| 水蜜桃什么品种好| 一级毛片 在线播放| 99国产精品免费福利视频| 国产片特级美女逼逼视频| 久久久久精品久久久久真实原创| 熟女av电影| 老司机亚洲免费影院| 最新中文字幕久久久久| 亚洲国产精品999| 下体分泌物呈黄色| 极品人妻少妇av视频| 一个人看视频在线观看www免费| 亚洲国产精品成人久久小说| 国产伦精品一区二区三区视频9| 欧美+日韩+精品|